Clinical Trials (5)
Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma
Started Apr 2025
24 enrolled
Hepatocellular Carcinoma (HCC)Unresectable Hepatocellular Carcinoma
Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma
Started Jul 2024
25 enrolled
Hepatocellular Carcinoma Non-resectable
Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Started May 2024
41 enrolled
Graft Vs Host DiseaseGraft-versus-host-diseaseGraft Versus Host Disease
Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
Started Oct 2023
45 enrolled
Carcinoma, Hepatocellular
A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants
Started Aug 2023
174 enrolled
Healthy Participants